Noninvasive Tests for Inflammatory Bowel Disease: A Meta-analysis
Gea A Holtman1, Yvonne Lisman-van Leeuwen1, Johannes B Reitsma2
1Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; and.
Pediatrics
|December 19, 2015
Summary
Symptoms alone are insufficient for diagnosing pediatric inflammatory bowel disease (IBD). Fecal calprotectin (FCal), C-reactive protein (CRP), and albumin tests help identify children at low or high risk for IBD.
Area of Science:
- Pediatric Gastroenterology
- Diagnostic Accuracy Studies
- Inflammatory Bowel Disease (IBD) Research
Background:
- Pediatric inflammatory bowel disease (IBD) often presents with non-specific symptoms that overlap with functional gastrointestinal disorders.
- Accurate diagnosis in children is crucial but challenging due to overlapping clinical presentations.
Purpose of the Study:
- To evaluate the diagnostic accuracy of various clinical factors in identifying pediatric IBD.
- To determine the effectiveness of symptoms, signs, and noninvasive tests in diagnosing IBD in children.
Main Methods:
- A comprehensive literature search was performed using Medline and Embase databases.
- Nineteen studies involving 2806 children with chronic gastrointestinal symptoms were analyzed for diagnostic accuracy.
- Study quality was assessed using the QUADAS-2 tool.
Main Results:
- Symptoms like abdominal pain and diarrhea showed variable sensitivity and specificity for IBD diagnosis.
- C-reactive protein (CRP) and albumin demonstrated moderate to high specificity.
- Fecal calprotectin (FCal) exhibited high sensitivity (0.99) and moderate specificity (0.65) for detecting IBD.
Conclusions:
- Clinical symptoms alone are inadequate for ruling out IBD in children.
- Fecal calprotectin (FCal), CRP, and albumin are valuable biomarkers for risk stratification in pediatric IBD diagnosis.
- Negative FCal results may indicate low risk, while positive CRP or albumin results suggest higher risk for IBD.
